ATLAS / Macro Radar / Reporting / VVOS

Vivos Therapeutics, Inc. (VVOS) reporting calendar

Vivos Therapeutics, Inc. files periodic reports with the SEC as VVOS on Nasdaq. Atlas tracks 22 filed reports for this issuer, each linked to its original EDGAR accession.

Next window
20 Jul 2026 – 18 Sep 2026
Latest report
10-Q
Period ended
31 Mar 2026
Filed
20 May 2026
Reports on record
22

How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 91-day cadence, filed a median 50 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.

Open VVOS market profile Latest filing on SEC EDGAR ↗ Surgical & Medical Instruments & Apparatus reporting datesAll Nasdaq reporting dates

Filed periodic reports

FormPeriod endedFiledLagSEC accession
10-Q31 Mar 202620 May 202650 days0001493152-26-024650
10-K31 Dec 202515 Apr 2026105 days0001493152-26-016854
10-Q30 Sep 202519 Nov 202550 days0001493152-25-024253
10-Q30 Jun 202519 Aug 202550 days0001641172-25-024832
10-Q31 Mar 202515 May 202545 days0001641172-25-010874
10-K31 Dec 202431 Mar 202590 days0001641172-25-001750
10-Q30 Sep 202414 Nov 202445 days0001493152-24-045888
10-Q30 Jun 202414 Aug 202445 days0001493152-24-032240
10-Q31 Mar 202414 May 202444 days0001493152-24-019247
10-K31 Dec 202328 Mar 202488 days0001493152-24-011755
10-Q30 Sep 202314 Nov 202345 days0001493152-23-041150
10-Q30 Jun 202316 Aug 202347 days0001493152-23-029161
10-Q31 Mar 20238 Jun 202369 days0001493152-23-020568
10-K31 Dec 202230 Mar 202389 days0001493152-23-009765
10-Q30 Sep 202220 Dec 202281 days0001493152-22-036000
10-Q30 Jun 202220 Dec 2022173 days0001493152-22-035993
10-Q31 Mar 202216 May 202246 days0001493152-22-013889
10-K31 Dec 202131 Mar 202290 days0001493152-22-008452
10-Q30 Sep 202115 Nov 202146 days0001493152-21-028596
10-Q30 Jun 202112 Aug 202143 days0001493152-21-019519
10-Q31 Mar 202117 May 202147 days0001493152-21-011847
10-K31 Dec 202025 Mar 202184 days0001493152-21-006806

Source: SEC EDGAR company submissions for CIK 0001716166. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.